Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma
Authors:
Open Access
- 12 February 2020
- journal article
- research article
- Published by Springer Nature in Immunity & Ageing
- Vol. 17 (1) , 1-11
Abstract
Introduction: The number of aging cancer patients has increased continuously and will do so further in the future. The immune system of elderly people experiences critical changes over the time. Therefore, tumor-induced changes in the immune system are believed to differ in young and elderly cancer patients as well.Methods: The effect of aging on the immune system was measured in peripheral blood lymphocytes (PBL) of healthy volunteers (n = 48, 21–84 yrs.) divided into three different age groups. Seventy years was set as a cut-off for defining subjects as elderly. Results were compared to two groups of adult cancer patients, which donated PBL and tumor infiltrating lymphocytes (TIL): young cancer patients (40–69 yrs.; blood:n = 13; TIL:n = 17) and elderly cancer patients (70–90 yrs.; blood:n = 20; TIL:n = 15) with head and neck squamous cell carcinoma (HNSCC). Frequencies and phenotypes of CD4+and CD8+T cells as well as regulatory T cells (Treg) were assessed by flow cytometry.Results: We observed lower frequencies of CD8+cytotoxic T cells during aging in both groups. Frequencies of tumor infiltrating regulatory T cells were significantly higher than in the peripheral blood but showed a significant decline in older tumor patients. With increasing age, expression of immunosuppressive CD73 and CCR7 was lower and expression of PD1 elevated on peripheral T cells in healthy volunteers and tumor patients.Conclusion: Immunosenescence takes place in healthy donors and cancer patients. Our results suggest that in elderly tumor patients, the immune system is impaired and the tumor-induced immune escape is less pronounced. The increased expression of PD1 implies the potential for effective immunotherapies in elderly, as treatment with checkpoint inhibitors could be more beneficial for elderly HNSCC patients.Keywords
This publication has 45 references indexed in Scilit:
- Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and SpainImmunity & Ageing, 2013
- Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsetsJournal of Immunological Methods, 2011
- Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinomaAuris Nasus Larynx, 2010
- Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for TherapyJNCI: Journal of the National Cancer Institute, 2008
- Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppressionBlood, 2007
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Naïve T Cells in the ElderlyAnnals of the New York Academy of Sciences, 2006
- Chemokine C Receptor 7 Expression and Protection of Circulating CD8+ T Lymphocytes from ApoptosisClinical Cancer Research, 2005
- Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissuesMolecular Immunology, 2005
- Does memory improve with age? CD85j (ILT‐2/LIR‐1) expression on CD8+ T cells correlates with ‘memory inflation’ in human cytomegalovirus infectionImmunology & Cell Biology, 2005